AMIVANTAMAB — all Canadian products
5 DINs
5 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is AMIVANTAMAB, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02526182 | RYBREVANT | JANSSEN INC | Solution | Intravenous | AMIVANTAMAB 350 MG | Marketed | |
| 02569140 | RYBREVANT SC | JANSSEN INC | Solution | Subcutaneous | AMIVANTAMAB 1600 MG | Marketed | |
| 02569159 | RYBREVANT SC | JANSSEN INC | Solution | Subcutaneous | AMIVANTAMAB 2240 MG | Marketed | |
| 02569167 | RYBREVANT SC | JANSSEN INC | Solution | Subcutaneous | AMIVANTAMAB 2400 MG | Marketed | |
| 02569175 | RYBREVANT SC | JANSSEN INC | Solution | Subcutaneous | AMIVANTAMAB 3520 MG | Marketed |
Browse other molecules: